Market Forecast By Modality (Veno-Arterial (VA), Veno-Venous (VV)), By Application (Respiratory Applications, Cardiac Applications, Extracorporeal Cardiopulmonary Resuscitation (ECPR)) And Competitive Landscape
| Product Code: ETC6007259 | Publication Date: Sep 2024 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
According to 6Wresearch internal database and industry insights, the Afghanistan Extra Corporeal Membrane Oxygenation System Market is projected to grow at a compound annual growth rate (CAGR) of 9.4% during the forecast period (2026–2032).
Below is the evaluation of the year-wise growth rate along with key drivers:
| Years | Estimated Annual Growth (%) | Growth Drivers |
| 2021 | 7.8% | A rise in the prevalence of critical respiratory and cardiac conditions requiring advanced life support. |
| 2022 | 8.1% | Rising awareness and adoption of ECMO therapies in major hospitals. |
| 2023 | 8.4% | A rise in the expansion of critical care infrastructure and intensive care units (ICUs). |
| 2024 | 8.8% | Increasing training and skilled workforce for ECMO procedures. |
| 2025 | 9.2% | Technological upgrades in ECMO systems and better clinical outcomes. |
The Afghanistan Extra Corporeal Membrane Oxygenation System Market report thoroughly covers the market by Modality and Application. The report provides detailed analysis of ongoing market trends, opportunities/high-growth areas, and market drivers, helping stakeholders devise and align their market strategies according to current and future market dynamics.
| Report Name | Afghanistan Extra Corporeal Membrane Oxygenation (ECMO) System Market |
| Forecast period | 2026–2032 |
| CAGR | 9.4% |
| Growing Sector | Healthcare & Critical Care |
The Afghanistan Extra Corporeal Membrane Oxygenation System Market is estimated to boost in the coming years as it is being driven by some major drivers, such as the rising prevalence of severe respiratory and cardiac conditions that need advanced life support therapies to treat these diseases. There is a rising adoption rate of ECMO systems in the country in hospitals and critical care centers. The market growth is further driven by ongoing improvements in critical care infrastructure and growing training programs for ECMO specialists.
Below mentioned are some prominent drivers and their influence on the market dynamics:
| Drivers | Primary Segments Affected | Why It Matters |
| Rising Critical Respiratory Cases | By Application (Respiratory Applications) | Increases demand for ECMO for severe respiratory failure management. |
| Growth in Cardiac Care Services | By Application (Cardiac Applications) | With more ICUs and critical care units, there will be a broader ECMO adoption. |
| A Rise in the Expansion of Critical Care Infrastructure | By Modality (VA, VV) | With more ICUs and critical care units, there will be a broader ECMO adoption. |
| Technological Upgrades | By Modality (VA, VV) | Modern ECMO systems provide better safety and efficiency, boosting usage. |
| Increase in Clinical Training Programs | By Application (ECPR) | Skilled clinicians improve access to ECMO therapy and patient outcomes. |
The Afghanistan Extra Corporeal Membrane Oxygenation System Market is projected to grow significantly at a CAGR of 9.4% during 2026–2032. Here are some important factors that are boosting this growth, include increased incidence of severe cardiac and respiratory disorders and the rising expansion of critical care facilities. Other factors proliferating this Afghanistan Extra Corporeal Membrane Oxygenation System Market growth are government support for advanced healthcare technologies, a rise in the clinical adoption of ECMO therapies, better training opportunities for healthcare professionals and improved patient survival benefits.
Below mentioned are some prominent restraints and their influence on the market dynamics:
| Restraints | Primary Segments Affected | What This Means |
| High Cost of ECMO Systems | By Modality (VA, VV) | High equipment and maintenance costs limit adoption in smaller hospitals. |
| Limited Skilled Workforce | By Application (ECPR) | There is a lack of trained ECMO specialists, which hinders procedure adoption. |
| Infrastructure Gaps in Rural Areas | By Application (Respiratory, Cardiac) | Lack of high-end critical care infrastructure limits access outside major cities. |
| Regulatory and Reimbursement Challenges | By Modality (VA, VV) | Inconsistent reimbursement policies may slow growth. |
| Costly Consumables and Accessories | By Application (All Applications) | High recurring costs for disposables increase total treatment expense. |
Despite the positive outlook of the Afghanistan Extra Corporeal Membrane Oxygenation System Market, it deals with numerous challenges, like high initial investment costs, limited access to trained clinical specialists, and inadequate critical care infrastructure in rural areas. Regulatory and reimbursement barriers may also limit widespread adoption. Although there are ongoing investments in healthcare upgrades and training programs, which are expected to gradually reduce these constraints.
Below mentioned are some major trends that are contributing to the Afghanistan Extra Corporeal Membrane Oxygenation System Market growth include:
Below mentioned are some major investment opportunities that are estimated to shape the dynamics of the market include:
Below is the list of prominent companies leading the Afghanistan Extra Corporeal Membrane Oxygenation System Market:
| Company Name | Maquet Getinge Group |
| Established | 1838 |
| Headquarters | Rastatt, Germany |
| Website | Click Here |
Maquet, a subsidiary of Getinge Group, provides advanced ECMO systems designed for both VA and VV applications. Its platforms integrate pumps, oxygenators, and monitoring technologies to support complex cardiac and respiratory cases.
| Company Name | Medtronic plc |
| Established | 1949 |
| Headquarters | Dublin, Ireland |
| Website | Click Here |
Medtronic offers comprehensive ECMO and cardiopulmonary support systems for critical care environments. Its devices are supported by strong clinical research and technical expertise.
| Company Name | Sorin Group (LivaNova) |
| Established | 1950 |
| Headquarters | London, UK |
| Website | Click Here |
LivaNova delivers innovative ECMO platforms designed for efficient respiratory and cardiac support. The company focuses on safety-enhanced oxygenators and pump technologies.
| Company Name | Terumo Corporation |
| Established | 1921 |
| Headquarters | Tokyo, Japan |
| Website | Click Here |
Terumo provides ECMO systems and related accessories tailored for acute and intensive care settings. The company emphasizes precision engineering and consistent clinical outcomes.
| Company Name | Medos International (Fresenius) |
| Established | 1971 |
| Headquarters | Germany |
| Website | Click Here |
Medos International, part of Fresenius, develops advanced ECMO equipment for cardiac and respiratory support. The company focuses on performance optimization and clinical efficiency.
According to Afghanistan’s government data, the Ministry of Public Health (MoPH) has released some key policies that are aimed at strengthening critical care services as well as improving access to advanced life-support technologies. At the same time, regulatory frameworks focus on compliance with international medical device safety standards and mandatory training certification for clinicians operating advanced life-support devices. For example, government-backed hospital modernization actions in tertiary care centers have supported the procurement of advanced ICU equipment, including ventilators and extracorporeal support systems, to enhance emergency and cardiac care services.
The Afghanistan Extra Corporeal Membrane Oxygenation System Market share is estimated to increase in the coming years, as it will be influenced by some major factors. Such as increasing investments in critical care infrastructure, rising cases of severe cardiac and respiratory illnesses, and greater demand for advanced life support technologies. There are ongoing training programs for clinicians and technological advancements in ECMO devices, which are expected to further strengthen market prospects.
The report offers a comprehensive study of the following market segments and their leading categories:
According to Avika, Senior Research Analyst, 6Wresearch, the Veno-Venous (VV) modality is expected to lead the market; this is due to its extensive use in managing severe respiratory failure cases. VV ECMO provides effective pulmonary support without directly supporting cardiac function, making it widely adopted in intensive care units for patients suffering from acute respiratory distress and other critical lung conditions.
Respiratory applications are projected to dominate the market. This growth is owing to the increasing incidence of severe respiratory disorders requiring advanced life support systems. The rising burden of acute respiratory failure and the growing need for temporary extracorporeal oxygenation support in critical care settings significantly drive the demand for ECMO systems in respiratory treatment.
The report subsequently covers the market by the following segments and subsegments:
|
1 Executive Summary |
|
2 Introduction |
|
2.1 Key Highlights of the Report |
|
2.2 Report Description |
|
2.3 Market Scope & Segmentation |
|
2.4 Research Methodology |
|
2.5 Assumptions |
|
3 Afghanistan Extra Corporeal Membrane Oxygenation System Market Overview |
|
3.1 Afghanistan Country Macro Economic Indicators |
|
3.2 Afghanistan Extra Corporeal Membrane Oxygenation System Market Revenues & Volume, 2022 & 2032F |
|
3.3 Afghanistan Extra Corporeal Membrane Oxygenation System Market - Industry Life Cycle |
|
3.4 Afghanistan Extra Corporeal Membrane Oxygenation System Market - Porter's Five Forces |
|
3.5 Afghanistan Extra Corporeal Membrane Oxygenation System Market Revenues & Volume Share, By Modality, 2022 & 2032F |
|
3.6 Afghanistan Extra Corporeal Membrane Oxygenation System Market Revenues & Volume Share, By Application, 2022 & 2032F |
|
4 Afghanistan Extra Corporeal Membrane Oxygenation System Market Dynamics |
|
4.1 Impact Analysis |
|
4.2 Market Drivers |
|
4.3 Market Restraints |
|
5 Afghanistan Extra Corporeal Membrane Oxygenation System Market Trends |
|
6 Afghanistan Extra Corporeal Membrane Oxygenation System Market, By Types |
|
6.1 Afghanistan Extra Corporeal Membrane Oxygenation System Market, By Modality |
|
6.1.1 Overview and Analysis |
|
6.1.2 Afghanistan Extra Corporeal Membrane Oxygenation System Market Revenues & Volume, By Modality, 2022- 2032F |
|
6.1.3 Afghanistan Extra Corporeal Membrane Oxygenation System Market Revenues & Volume, By Veno-Arterial (VA), 2022- 2032F |
|
6.1.4 Afghanistan Extra Corporeal Membrane Oxygenation System Market Revenues & Volume, By Veno-Venous (VV), 2022- 2032F |
|
6.2 Afghanistan Extra Corporeal Membrane Oxygenation System Market, By Application |
|
6.2.1 Overview and Analysis |
|
6.2.2 Afghanistan Extra Corporeal Membrane Oxygenation System Market Revenues & Volume, By Respiratory Applications, 2022- 2032F |
|
6.2.3 Afghanistan Extra Corporeal Membrane Oxygenation System Market Revenues & Volume, By Cardiac Applications, 2022- 2032F |
|
6.2.4 Afghanistan Extra Corporeal Membrane Oxygenation System Market Revenues & Volume, By Extracorporeal Cardiopulmonary Resuscitation (ECPR), 2022- 2032F |
|
7 Afghanistan Extra Corporeal Membrane Oxygenation System Market Import-Export Trade Statistics |
|
7.1 Afghanistan Extra Corporeal Membrane Oxygenation System Market Export to Major Countries |
|
7.2 Afghanistan Extra Corporeal Membrane Oxygenation System Market Imports from Major Countries |
|
8 Afghanistan Extra Corporeal Membrane Oxygenation System Market Key Performance Indicators |
|
9 Afghanistan Extra Corporeal Membrane Oxygenation System Market - Opportunity Assessment |
|
9.1 Afghanistan Extra Corporeal Membrane Oxygenation System Market Opportunity Assessment, By Modality, 2022 & 2032F |
|
9.2 Afghanistan Extra Corporeal Membrane Oxygenation System Market Opportunity Assessment, By Application, 2022 & 2032F |
|
10 Afghanistan Extra Corporeal Membrane Oxygenation System Market - Competitive Landscape |
|
10.1 Afghanistan Extra Corporeal Membrane Oxygenation System Market Revenue Share, By Companies, 2025 |
|
10.2 Afghanistan Extra Corporeal Membrane Oxygenation System Market Competitive Benchmarking, By Operating and Technical Parameters |
|
11 Company Profiles |
|
12 Recommendations |
|
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here